Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | S24 - Epilepsy Clinical Syndromes and Management

Tuesday 04/16/24
03:30 PM - 05:30 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 3E-H
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Epilepsy/Clinical Neurophysiology (EEG)
 A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes for question and answer with the author. 
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM MDT Abstract 001 - Long-term Clinical Outcome of Cryptogenic New-onset Refractory Status Epilepticus (C-NORSE) Patients
Yoonhyuk Jang
03:42 PM - 03:54 PM MDT Abstract 002 - Does Treatment-resistant Epilepsy Get Better or Worse Over Time?
Ojas Potnis
03:54 PM - 04:06 PM MDT Abstract 003 - Cardiac Biomarkers for SUDEP: Retrospective Evaluation of Nine Patients with EMU Admissions
Alejandra Duque Ramirez, MD
04:06 PM - 04:18 PM MDT Abstract 004 - Effects of Depression on Clinical Outcomes in Cognitively Impaired Patients with Epilepsy
Jiping Zhou, MD, MPH
04:18 PM - 04:30 PM MDT Abstract 005 - Acute Postictal Changes in Mood
Amit Ahituv
04:30 PM - 04:42 PM MDT Abstract 006 - Autism Spectrum Disorder in Children with Infantile Epileptic Spasms: Prevalence and Risk Factors
Aria Francesca Terango
04:42 PM - 04:54 PM MDT Abstract 007 - Assessing the Clinical and Treatment Landscape of Genetic Epilepsies Through 3,760 Individuals
Julie Xian
04:54 PM - 05:06 PM MDT Abstract 008 - Factors Associated with Frequent Emergency Visits for Seizure/Epilepsy: A Multi-state Analysis
Uma Sarwadnya
05:06 PM - 05:18 PM MDT Abstract 009 - Emergency Department Treatment of Alcohol-associated Seizures in Detroit: A Multicenter Retrospective Study
Tabassum Chowdhury
05:18 PM - 05:30 PM MDT Abstract 010 - Disparities in Epilepsy Surgery for Medically Refractory Epilepsy: Insights from the National Inpatient Sample Database (2016-2019)
Prabandh Reddy Buchhanolla, MBBS
Faculty Disclosures
Jacqueline French, MD, FAAN Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Charles Akos Szabo, MD, FAAN Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Gary Raymond Cutter, PhD Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Eric D. Marsh, MD, PhD Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Meriem K. Bensalem Owen, MD The institution of Dr. Bensalem Owen has received research support from NIH. The institution of Dr. Bensalem Owen has received research support from Xenon. The institution of Dr. Bensalem Owen has received research support from UCB. The institution of Dr. Bensalem Owen has received research support from NeuroPace.
Sang Kun Lee, MD Prof. Lee has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Kon Chu, MD, PhD Prof. Chu has nothing to disclose.
Soon-Tae Lee, MD, PhD Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Autoimmune Encephalitis Alliance. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Shavonne Massey, MD Dr. Massey has a non-compensated relationship as a consultant with Sun Pharmaceutical Ltd that is relevant to AAN interests or activities.
Maysaa Merhi Basha, MD Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Pamela Pojomovsky McDonnell, MD Dr. Pojomovsky McDonnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Pojomovsky McDonnell has received research support from AAN.
Michelle Fabian, MD, FAAN Dr. Fabian has nothing to disclose.
Shaun Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
Rohit Ajay Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Xilma R. Ortiz-Gonzalez, MD, PhD The institution of Dr. Ortiz-Gonzalez has received research support from Robert Wood Johnson Foundation . The institution of Dr. Ortiz-Gonzalez has received research support from NINDS.
Sasha Alick-Lindstrom, MD, FAAN, FACNS,FAES Dr. Alick-Lindstrom has nothing to disclose.
Ritesh Ramdhani, MD Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Hiroki Nariai, MD Dr. Nariai has nothing to disclose.
Brad Kenichi Kamitaki, MD Dr. Kamitaki has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brown and Brown Absence Services Group. The institution of Dr. Kamitaki has received research support from American Epilepsy Society. The institution of Dr. Kamitaki has received research support from New Jersey Health Foundation.
Ethan M. Goldberg, MD, PhD Dr. Goldberg has nothing to disclose.
Claude Steriade, MD The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals.
Lakshmi S. Amaravadi, PhD No disclosure on file
Vijayakumar Javalkar, MD, FAAN Dr. Javalkar has nothing to disclose.
Rajsekar R. Rajaraman, MD Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Colin A. Ellis, MD Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder.
Mark Patrick Fitzgerald, MD, PhD Dr. Fitzgerald has nothing to disclose.
Charles Linder No disclosure on file
Eda Coban No disclosure on file
Monika Satoskar No disclosure on file
Gulten Ozdemir No disclosure on file
Irwin Hollander, PhD No disclosure on file
Kinjal Doshi No disclosure on file
James Fortenberry No disclosure on file
Alejandra Duque Ramirez, MD Dr. Duque Ramirez has nothing to disclose.
Mostafa Hotait, MD Dr. Hotait has nothing to disclose.
Naomi Lewin, MD Dr. Lewin has nothing to disclose.
Roohi Katyal, MD Dr. Katyal has nothing to disclose.
Vishnu Anand Cuddapah, MD The institution of Dr. Cuddapah has received research support from NIH. The institution of Dr. Cuddapah has received research support from CURE Epilepsy.
Saurabh Kataria, MD Dr. Kataria has nothing to disclose.
Sarah Frances Tefft Ms. Tefft has nothing to disclose.
Jiping Zhou, MD, MPH Dr. Zhou has nothing to disclose.
Lauren Waldron, MD Dr. Waldron has nothing to disclose.
Abdullahi Musa Adamu, MBBS Dr. Adamu has nothing to disclose.
Asra Tanwir, MD, MBBS Dr. Tanwir has nothing to disclose.
Manik Tetarbe, MD Dr. Tetarbe has nothing to disclose.
Yoonhyuk Jang Mr. Jang has nothing to disclose.
Han Sang Lee Han Sang Lee has nothing to disclose.
Jennifer Dai Ms. Dai has nothing to disclose.
Prabandh Reddy Buchhanolla, MBBS Dr. Buchhanolla has nothing to disclose.
Caitlin Grzeskowiak, PhD Ms. Grzeskowiak has received personal compensation for serving as an employee of Epilepsy Foundation. Ms. Grzeskowiak has received personal compensation for serving as an employee of Project Data Sphere.
Jason Liu Mr. Liu has nothing to disclose.
Tabassum Chowdhury Ms. Chowdhury has nothing to disclose.
Kyung Il Park, MD,PhD Prof. Park has nothing to disclose.
Soo Hyun Ahn, MD Dr. Ahn has nothing to disclose.
Shatha Wahbi Ms. Wahbi has nothing to disclose.
Monika Thapa, MBBS Dr. Thapa has nothing to disclose.
Amit Ahituv Ms. Ahituv has nothing to disclose.
Eden Tefera, BS Ms. Tefera has nothing to disclose.
Melissa Ly Miss Ly has nothing to disclose.
Gabriel Biondo Mr. Biondo has nothing to disclose.
Anureet Kaur, Other Miss Kaur has nothing to disclose.
Joseph Medina Mr. Medina has nothing to disclose.
Julie Xian Miss Xian has nothing to disclose.
Ojas Potnis Mr. Potnis has nothing to disclose.
Jennifer Geller Miss Geller has nothing to disclose.
Kylie Getz Miss Getz has nothing to disclose.
Maria Pleshkevich, Other Ms. Pleshkevich has nothing to disclose.
Uma Sarwadnya Miss Sarwadnya has nothing to disclose.
Leila Alidoost, Other Ms. Alidoost has nothing to disclose.
Aria Francesca Terango Miss Terango has nothing to disclose.
Ingo Helbig Dr. Helbig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Encoded. Dr. Helbig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Helbig has received intellectual property interests from a discovery or technology relating to health care.
Lakshmi Mounika Chandaluri, MBBS Dr. Chandaluri has nothing to disclose.
JI HYE YOU, NP Ms. YOU has nothing to disclose.
Su Yee Mon, Other Miss Mon has nothing to disclose.
Laina Lusk, Other The institution of Miss Lusk has received research support from NIH. The institution of Miss Lusk has received research support from CACNA1A Foundation.
Sarah Ruggiero, Other The institution of Mrs. Ruggiero has received research support from STXBP1 Disorders Foundation.
Mark Ramos Mr. Ramos has nothing to disclose.
Rachel Sukonnik Miss Sukonnik has nothing to disclose.
Amanda Back, Other Ms. Back has nothing to disclose.
Stacey Cohen, Other Ms. Cohen has nothing to disclose.
Michael C. Kaufman, Other Mr. Kaufman has nothing to disclose.
Rujuta Sathe Ms. Sathe has nothing to disclose.
Katie Rose Sullivan, Other Ms. Sullivan has nothing to disclose.
Natalie Ginn, Other Ms. Ginn has nothing to disclose.
Norah Gidanian, Other Miss Gidanian has nothing to disclose.
David Tabibzadeh Mr. Tabibzadeh has nothing to disclose.
Emmi Deckard Miss Deckard has nothing to disclose.
Katherine Helbig Ms. Helbig has nothing to disclose.
Alexander K. Gonzalez Mr. Gonzalez has nothing to disclose.
Katherine *use 153550 Taub, MD Dr. Taub has nothing to disclose.
Lea Bailey-Medley Ms. Bailey-Medley has nothing to disclose.